Replimune Group, Inc. (REPL)

8.07 +1.03 (+14.63%) USD  |  NASDAQ  |  Mar 06, 16:00
9.21 +1.14 (+14.13%) After-Hours: 20:00
More

Replimune Group Sale of PPE (5 Year Growth)

Sale of PPE (5 Year Growth) Chart

View Sale of PPE (5 Year Growth) for REPL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Sale of PPE (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Sale of PPE (5 Year Growth) Range, Past 5 Years

View Sale of PPE (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Sale of PPE (5 Year Growth) Benchmarks

View Sale of PPE (5 Year Growth) Benchmarks
Start Trial
Catalyst Pharmaceuticals, Inc. --
Sarepta Therapeutics, Inc. --
REGENXBIO, Inc. --
Bristol Myers Squibb Co. --
Mirum Pharmaceuticals, Inc. --